Lamivudine plus adefovir combination therapy for lamivudine resistance in hepatitis-B-related hepatocellular carcinoma patients

Clinical and molecular hepatology

Volumn 19, Issue 3, 2013, Pages 273-279

  Kim, Jeong H an ^a   Ko, Soon Y oung ^a   Choe, Won H yeok ^a   Kwon, So Y oung ^a   Lee, Chang H ong ^a  

^a Konkuk University School of Medicine   (South Korea)

Author keywords

Adefovir; Chronic hepatitis B; Hepatocellular carcinoma; Lamivudine; Resistance

Indexed keywords

ADEFOVIR; ADENINE; ANTIVIRUS AGENT; LAMIVUDINE; PHOSPHONIC ACID DERIVATIVE; VIRUS DNA;

ADULT; ANALOGS AND DERIVATIVES; ANTIVIRAL RESISTANCE; CARCINOMA, HEPATOCELLULAR; COMBINATION DRUG THERAPY; DRUG ADMINISTRATION; GENETICS; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMAN; INCIDENCE; LIVER CIRRHOSIS; LIVER NEOPLASMS; MIDDLE AGED; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VIROLOGY;

ADENINE; ADULT; ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; DNA, VIRAL; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, VIRAL; DRUG THERAPY, COMBINATION; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INCIDENCE; LAMIVUDINE; LIVER CIRRHOSIS; LIVER NEOPLASMS; MIDDLE AGED; ORGANOPHOSPHONATES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84899038334     PISSN: None     EISSN: 2287285X     Source Type: Journal    
DOI: 10.3350/cmh.2013.19.3.273     Document Type: Article

References (0)